Press page

Welcome to the official press page of Sanity Group!
All relevant contents for media representatives in one place.

Press Contact

For all kinds of media inquiries

Jennifer Plankenbuehler

Lead Medical PR| Press Officer

Email: jennifer.plankenbuhler@sanitygroup.com | presse@sanitygroup.com

Phone: +49 173 37 62 845

For marketing/advertising or any other inquiries please contact: info@sanitygroup.com

Sanity Group GmbH
Jägerstraße 28-31 | 10117 Berlin | Germany

Contact for all kinds of media inquiries

Ms Jennifer Plankenbuehler

Lead Medical PR | Press Officer

Email: jennifer.plankenbuhler@sanitygroup.com | presse@sanitygroup.com

Phone: +49 173 37 62 845

For marketing/advertising or any other inquiries please contact: info@sanitygroup.com

Address
Headquarter

Sanity Group | Jägerstr. 28-31 | 10117 Berlin | Germany

About Sanity Group

The Berlin-based health and life science company Sanity Group aims to improve people’s quality of life through the use of cannabinoids and the utilization of the endocannabinoid system. The focus is on pharmaceuticals (medical cannabis; finished pharmaceuticals) and medical products on the one hand, and cannabinoid-based consumer goods on the other. Sanity Group, founded in Berlin in 2018 by Finn Age Hänsel and Fabian Friede, is supported financially and strategically by investors such as Casa Verde Capital (Snoop Dogg), Navy Capital, Redalpine, HV Capital, Calyx, Cherry Ventures, Bitburger Ventures, SOJE Capital, and various business angels and celebrities such as Will.i.am (Black Eyed Peas), Scooter Braun, Hollywood actor Alyssa Milano and German soccer player Mario Götze.

The Berlin-based health and life science company Sanity Group aims to improve people’s quality of life through the use of cannabinoids and the utilization of the endocannabinoid system. The focus is on pharmaceuticals (medical cannabis; finished pharmaceuticals) and medical products on the one hand, and cannabinoid-based consumer goods on the other.

Sanity Group, founded in Berlin in 2018 by Finn Age Hänsel and Fabian Friede, is supported financially and strategically by investors such as Casa Verde Capital (Snoop Dogg), Navy Capital, Redalpine, HV Capital, Calyx, Cherry Ventures, Bitburger Ventures, SOJE Capital, and various business angels and celebrities such as Will.i.am (Black Eyed Peas), Scooter Braun, Hollywood actor Alyssa Milano and German soccer player Mario Götze.

What we do:

Medical & Pharma

Sanity Group’s medical business, including medical cannabis brands Vayamed and AVAAY Medical, and subsidiaries Belfry Medical (medical products & digital applications) and Endosane Pharmaceuticals (finished pharmaceuticals).

Extraction & Processing

Near Frankfurt am Main, Germany, Sanity Group operates a cannabis extract production and processing facility with laboratory.

Consumer Health

Sanity Group’s Consumer business with the brands VAAY (wellbeing) and This Place (functional natural cosmetics); further brands are planned.

2018

Sanity Group was founded by Finn Hänsel (CEO) and Fabian Friede (now works as a consultant)

Berlin

is the location of our headquarter; near Frankfurt am Main is our extraction & processing facility located

100+ Mio $

Total investment (after Series B funding round); Europe’s best-funded cannabis company

120+

Employees from over 15 different nations

50/50

Balanced gender ratio in the team

34,2 y

ø Average age of all employees

“Unfortunately, Cannabis still has very often a negative stigma attached to it. We want to give the plant a new chance, because what people associate with it is based on old prejudices. It’s important to us to actively contribute to education and knowledge transfer. This also involves showing decision-makers the differences between cannabis as a medicine, agricultural substance and lifestyle product. It’s important to understand the full potential of the plant – that’s what we’re working for, to bring cannabis back to the center of European society.”

– Finn Hänsel
Founder & Managing Director, Sanity Group

Downloads & pictures

Press pictures & Logo | Media kit | Speaker’s Profiles

Media center:
Pictures & Logo

Download portraits of our founders & management and press images in high-res and web optimized resolution.

Media kit

All information about Sanity Group in our digital press kit (PDF). Including factsheet, quotes and portrait (only available in German!).

Speaker's
Profiles

Short biographies & careers of Sanity Group founders Finn Hänsel and Fabian Friede (PDF) in German & English.

Latest News

Federal Council: Cannabis Legalization to Take Effect on April 1st

With the passage through the Federal Council, the planned partial legalization of cannabis in Germany has successfully cleared the final parliamentary hurdle today: The Cannabis Act “CanG” (Pillar 1) officially comes into effect on April 1st, as the convocation of the compromise committee did not materialize. In today’s vote, a minority advocated for a compromise committee, while the majority abstained or voted against. For the German cannabis industry, this marks an important, albeit only initial step, states Finn Hänsel, founder and CEO of the Berlin-based cannabis company Sanity Group: “The foundation for the decriminalization and destigmatization of consumers, but above all, for better patient care with medicinal cannabis, has been laid today. Now the real work begins.” A timely implementation of the second pillar of CanG is now essential. In the medical context, due to the removal of cannabis from the Narcotics Act, a significant increase in the number of patients is expected, as access to this form of therapy is significantly simplified.

Read more

Europe’s first legal cannabis specialist store has opened: “Grashaus Projects” in Switzerland officially launched

Press release –– In a historic step, Switzerland and Europe are breaking new ground: this week, the first legal cannabis store in Europe officially opened its doors in the municipality of Allschwil in the north-western Swiss canton of Basel-Landschaft. To mark the start of the Grashaus Projects pilot project for the controlled distribution of cannabis for recreational purposes, study participants in Basel-Landschaft can now purchase various THC-containing cannabis products – from flowers to hashish, extracts, vape liquids and edibles – at the store under the guidance of trained specialist staff. It is the first store of its kind on the European continent.

Read more

First legal cannabis dispensaries in Europe: Sanity Group and ISGF get green light for a cannabis study in Swiss canton Basel-Landschaft

Sanity Group and the Swiss Institute for Addiction and Health Research (ISGF) received final approval from the Swiss Federal Office of Public Health (BAG) to conduct a study on the controlled dispensing of recreational cannabis in the canton of Basel-Landschaft, Switzerland. The aim of the study is to learn more about the effects of controlled access to cannabis and thus provide a solid scientific basis for possible decisions on future cannabis regulation in Switzerland. The study with the title “Grashaus Projects” is scheduled to launch later this year. It will initially be dispensed through an initial store in the municipality of Allschwil, with another location in Liestal to follow. Sanity Group is the only German company participating in the Swiss pilot projects.

Read more

Sanity Group in the media

Interesting articles:

Previous slide
Next slide

Subscribe to press releases

We are happy to provide journalists, bloggers and media representatives with relevant information about Sanity Group on a regular basis. Subscribe to our press distribution list to receive our press releases directly in the future.

We would also be pleased if you keep us informed about publications and send us a specimen copy (gladly as a PDF) to presse@sanitygroup.com. Thank you very much!